0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Active Medical Implantable Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-16G17025
Home | Market Reports | Health| Medical Devices & Equipment
Global Active Medical Implantable Devices Market Research Report 2024
BUY CHAPTERS

Global Active Medical Implantable Devices Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16G17025
Report
November 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Active Medical Implantable Devices Market

The global Active Medical Implantable Devices market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Active Medical Implantable Devices leading manufacturers including NeuroPace, Axonics, Nevro Corp, Biotronik, Abiomed, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler, Sonova Holding, etc., dominate supply; the top five capture approximately % of global revenue, with NeuroPace leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Active Medical Implantable Devices market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Active Medical Implantable Devices Market Report

Report Metric Details
Report Name Active Medical Implantable Devices Market
Segment by Type
  • Implantable Cardiac Pacemaker
  • Electroencephalographic Stimulator
  • Cochlear Implant
  • Gastric Stimulator
  • Implantable Infusion Pump
  • Other
Segment by Application
  • Hospitals
  • Specialty Clinic
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company NeuroPace, Axonics, Nevro Corp, Biotronik, Abiomed, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler, Sonova Holding, Demant, Cochlear, Oticon Medical, MED-EL Medical Electronics, Masimo, Hologic, Varian Medical Systems
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Active Medical Implantable Devices study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Active Medical Implantable Devices Market report?

Ans: The main players in the Active Medical Implantable Devices Market are NeuroPace, Axonics, Nevro Corp, Biotronik, Abiomed, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler, Sonova Holding, Demant, Cochlear, Oticon Medical, MED-EL Medical Electronics, Masimo, Hologic, Varian Medical Systems

What are the Application segmentation covered in the Active Medical Implantable Devices Market report?

Ans: The Applications covered in the Active Medical Implantable Devices Market report are Hospitals, Specialty Clinic, Other

What are the Type segmentation covered in the Active Medical Implantable Devices Market report?

Ans: The Types covered in the Active Medical Implantable Devices Market report are Implantable Cardiac Pacemaker, Electroencephalographic Stimulator, Cochlear Implant, Gastric Stimulator, Implantable Infusion Pump, Other

1 Study Coverage
1.1 Introduction to Active Medical Implantable Devices: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Active Medical Implantable Devices Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Implantable Cardiac Pacemaker
1.2.3 Electroencephalographic Stimulator
1.2.4 Cochlear Implant
1.2.5 Gastric Stimulator
1.2.6 Implantable Infusion Pump
1.2.7 Other
1.3 Market Segmentation by Application
1.3.1 Global Active Medical Implantable Devices Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Specialty Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Active Medical Implantable Devices Revenue Estimates and Forecasts 2020-2031
2.2 Global Active Medical Implantable Devices Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Active Medical Implantable Devices Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Active Medical Implantable Devices Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Implantable Cardiac Pacemaker Market Size by Players
3.3.2 Electroencephalographic Stimulator Market Size by Players
3.3.3 Cochlear Implant Market Size by Players
3.3.4 Gastric Stimulator Market Size by Players
3.3.5 Implantable Infusion Pump Market Size by Players
3.3.6 Other Market Size by Players
3.4 Global Active Medical Implantable Devices Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Active Medical Implantable Devices Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Active Medical Implantable Devices Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Active Medical Implantable Devices Market Size by Type (2020-2031)
6.4 North America Active Medical Implantable Devices Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Active Medical Implantable Devices Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Active Medical Implantable Devices Market Size by Type (2020-2031)
7.4 Europe Active Medical Implantable Devices Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Active Medical Implantable Devices Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Active Medical Implantable Devices Market Size by Type (2020-2031)
8.4 Asia-Pacific Active Medical Implantable Devices Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Active Medical Implantable Devices Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Active Medical Implantable Devices Market Size by Type (2020-2031)
9.4 Central and South America Active Medical Implantable Devices Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Active Medical Implantable Devices Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Active Medical Implantable Devices Market Size by Type (2020-2031)
10.4 Middle East and Africa Active Medical Implantable Devices Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Active Medical Implantable Devices Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 NeuroPace
11.1.1 NeuroPace Corporation Information
11.1.2 NeuroPace Business Overview
11.1.3 NeuroPace Active Medical Implantable Devices Product Features and Attributes
11.1.4 NeuroPace Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.1.5 NeuroPace Active Medical Implantable Devices Revenue by Product in 2024
11.1.6 NeuroPace Active Medical Implantable Devices Revenue by Application in 2024
11.1.7 NeuroPace Active Medical Implantable Devices Revenue by Geographic Area in 2024
11.1.8 NeuroPace Active Medical Implantable Devices SWOT Analysis
11.1.9 NeuroPace Recent Developments
11.2 Axonics
11.2.1 Axonics Corporation Information
11.2.2 Axonics Business Overview
11.2.3 Axonics Active Medical Implantable Devices Product Features and Attributes
11.2.4 Axonics Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.2.5 Axonics Active Medical Implantable Devices Revenue by Product in 2024
11.2.6 Axonics Active Medical Implantable Devices Revenue by Application in 2024
11.2.7 Axonics Active Medical Implantable Devices Revenue by Geographic Area in 2024
11.2.8 Axonics Active Medical Implantable Devices SWOT Analysis
11.2.9 Axonics Recent Developments
11.3 Nevro Corp
11.3.1 Nevro Corp Corporation Information
11.3.2 Nevro Corp Business Overview
11.3.3 Nevro Corp Active Medical Implantable Devices Product Features and Attributes
11.3.4 Nevro Corp Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.3.5 Nevro Corp Active Medical Implantable Devices Revenue by Product in 2024
11.3.6 Nevro Corp Active Medical Implantable Devices Revenue by Application in 2024
11.3.7 Nevro Corp Active Medical Implantable Devices Revenue by Geographic Area in 2024
11.3.8 Nevro Corp Active Medical Implantable Devices SWOT Analysis
11.3.9 Nevro Corp Recent Developments
11.4 Biotronik
11.4.1 Biotronik Corporation Information
11.4.2 Biotronik Business Overview
11.4.3 Biotronik Active Medical Implantable Devices Product Features and Attributes
11.4.4 Biotronik Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.4.5 Biotronik Active Medical Implantable Devices Revenue by Product in 2024
11.4.6 Biotronik Active Medical Implantable Devices Revenue by Application in 2024
11.4.7 Biotronik Active Medical Implantable Devices Revenue by Geographic Area in 2024
11.4.8 Biotronik Active Medical Implantable Devices SWOT Analysis
11.4.9 Biotronik Recent Developments
11.5 Abiomed
11.5.1 Abiomed Corporation Information
11.5.2 Abiomed Business Overview
11.5.3 Abiomed Active Medical Implantable Devices Product Features and Attributes
11.5.4 Abiomed Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.5.5 Abiomed Active Medical Implantable Devices Revenue by Product in 2024
11.5.6 Abiomed Active Medical Implantable Devices Revenue by Application in 2024
11.5.7 Abiomed Active Medical Implantable Devices Revenue by Geographic Area in 2024
11.5.8 Abiomed Active Medical Implantable Devices SWOT Analysis
11.5.9 Abiomed Recent Developments
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Corporation Information
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Active Medical Implantable Devices Product Features and Attributes
11.6.4 Boston Scientific Corporation Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.6.5 Boston Scientific Corporation Recent Developments
11.7 Medtronic
11.7.1 Medtronic Corporation Information
11.7.2 Medtronic Business Overview
11.7.3 Medtronic Active Medical Implantable Devices Product Features and Attributes
11.7.4 Medtronic Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.7.5 Medtronic Recent Developments
11.8 Abbott
11.8.1 Abbott Corporation Information
11.8.2 Abbott Business Overview
11.8.3 Abbott Active Medical Implantable Devices Product Features and Attributes
11.8.4 Abbott Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.8.5 Abbott Recent Developments
11.9 Eckert & Ziegler
11.9.1 Eckert & Ziegler Corporation Information
11.9.2 Eckert & Ziegler Business Overview
11.9.3 Eckert & Ziegler Active Medical Implantable Devices Product Features and Attributes
11.9.4 Eckert & Ziegler Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.9.5 Eckert & Ziegler Recent Developments
11.10 Sonova Holding
11.10.1 Sonova Holding Corporation Information
11.10.2 Sonova Holding Business Overview
11.10.3 Sonova Holding Active Medical Implantable Devices Product Features and Attributes
11.10.4 Sonova Holding Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Demant
11.11.1 Demant Corporation Information
11.11.2 Demant Business Overview
11.11.3 Demant Active Medical Implantable Devices Product Features and Attributes
11.11.4 Demant Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.11.5 Demant Recent Developments
11.12 Cochlear
11.12.1 Cochlear Corporation Information
11.12.2 Cochlear Business Overview
11.12.3 Cochlear Active Medical Implantable Devices Product Features and Attributes
11.12.4 Cochlear Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.12.5 Cochlear Recent Developments
11.13 Oticon Medical
11.13.1 Oticon Medical Corporation Information
11.13.2 Oticon Medical Business Overview
11.13.3 Oticon Medical Active Medical Implantable Devices Product Features and Attributes
11.13.4 Oticon Medical Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.13.5 Oticon Medical Recent Developments
11.14 MED-EL Medical Electronics
11.14.1 MED-EL Medical Electronics Corporation Information
11.14.2 MED-EL Medical Electronics Business Overview
11.14.3 MED-EL Medical Electronics Active Medical Implantable Devices Product Features and Attributes
11.14.4 MED-EL Medical Electronics Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.14.5 MED-EL Medical Electronics Recent Developments
11.15 Masimo
11.15.1 Masimo Corporation Information
11.15.2 Masimo Business Overview
11.15.3 Masimo Active Medical Implantable Devices Product Features and Attributes
11.15.4 Masimo Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.15.5 Masimo Recent Developments
11.16 Hologic
11.16.1 Hologic Corporation Information
11.16.2 Hologic Business Overview
11.16.3 Hologic Active Medical Implantable Devices Product Features and Attributes
11.16.4 Hologic Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.16.5 Hologic Recent Developments
11.17 Varian Medical Systems
11.17.1 Varian Medical Systems Corporation Information
11.17.2 Varian Medical Systems Business Overview
11.17.3 Varian Medical Systems Active Medical Implantable Devices Product Features and Attributes
11.17.4 Varian Medical Systems Active Medical Implantable Devices Revenue and Gross Margin (2020-2025)
11.17.5 Varian Medical Systems Recent Developments
12 Active Medical Implantable DevicesIndustry Chain Analysis
12.1 Active Medical Implantable Devices Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Active Medical Implantable Devices Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Active Medical Implantable Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Active Medical Implantable Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Active Medical Implantable Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Active Medical Implantable Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Active Medical Implantable Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Active Medical Implantable Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Active Medical Implantable Devices Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Active Medical Implantable Devices Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Active Medical Implantable Devices by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Medical Implantable Devices as of 2024)
 Table 11. Global Active Medical Implantable Devices Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Active Medical Implantable Devices Companies Headquarters
 Table 13. Global Active Medical Implantable Devices Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Active Medical Implantable Devices Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Active Medical Implantable Devices Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Active Medical Implantable Devices Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Active Medical Implantable Devices Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Active Medical Implantable Devices High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Active Medical Implantable Devices Growth Accelerators and Market Barriers
 Table 25. North America Active Medical Implantable Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Active Medical Implantable Devices Growth Accelerators and Market Barriers
 Table 27. Europe Active Medical Implantable Devices Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Active Medical Implantable Devices Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Active Medical Implantable Devices Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Active Medical Implantable Devices Investment Opportunities and Key Challenges
 Table 31. Central and South America Active Medical Implantable Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Active Medical Implantable Devices Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Active Medical Implantable Devices Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. NeuroPace Corporation Information
 Table 35. NeuroPace Description and Major Businesses
 Table 36. NeuroPace Product Features and Attributes
 Table 37. NeuroPace Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. NeuroPace Revenue Proportion by Product in 2024
 Table 39. NeuroPace Revenue Proportion by Application in 2024
 Table 40. NeuroPace Revenue Proportion by Geographic Area in 2024
 Table 41. NeuroPace Active Medical Implantable Devices SWOT Analysis
 Table 42. NeuroPace Recent Developments
 Table 43. Axonics Corporation Information
 Table 44. Axonics Description and Major Businesses
 Table 45. Axonics Product Features and Attributes
 Table 46. Axonics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Axonics Revenue Proportion by Product in 2024
 Table 48. Axonics Revenue Proportion by Application in 2024
 Table 49. Axonics Revenue Proportion by Geographic Area in 2024
 Table 50. Axonics Active Medical Implantable Devices SWOT Analysis
 Table 51. Axonics Recent Developments
 Table 52. Nevro Corp Corporation Information
 Table 53. Nevro Corp Description and Major Businesses
 Table 54. Nevro Corp Product Features and Attributes
 Table 55. Nevro Corp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Nevro Corp Revenue Proportion by Product in 2024
 Table 57. Nevro Corp Revenue Proportion by Application in 2024
 Table 58. Nevro Corp Revenue Proportion by Geographic Area in 2024
 Table 59. Nevro Corp Active Medical Implantable Devices SWOT Analysis
 Table 60. Nevro Corp Recent Developments
 Table 61. Biotronik Corporation Information
 Table 62. Biotronik Description and Major Businesses
 Table 63. Biotronik Product Features and Attributes
 Table 64. Biotronik Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Biotronik Revenue Proportion by Product in 2024
 Table 66. Biotronik Revenue Proportion by Application in 2024
 Table 67. Biotronik Revenue Proportion by Geographic Area in 2024
 Table 68. Biotronik Active Medical Implantable Devices SWOT Analysis
 Table 69. Biotronik Recent Developments
 Table 70. Abiomed Corporation Information
 Table 71. Abiomed Description and Major Businesses
 Table 72. Abiomed Product Features and Attributes
 Table 73. Abiomed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Abiomed Revenue Proportion by Product in 2024
 Table 75. Abiomed Revenue Proportion by Application in 2024
 Table 76. Abiomed Revenue Proportion by Geographic Area in 2024
 Table 77. Abiomed Active Medical Implantable Devices SWOT Analysis
 Table 78. Abiomed Recent Developments
 Table 79. Boston Scientific Corporation Corporation Information
 Table 80. Boston Scientific Corporation Description and Major Businesses
 Table 81. Boston Scientific Corporation Product Features and Attributes
 Table 82. Boston Scientific Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Boston Scientific Corporation Recent Developments
 Table 84. Medtronic Corporation Information
 Table 85. Medtronic Description and Major Businesses
 Table 86. Medtronic Product Features and Attributes
 Table 87. Medtronic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Medtronic Recent Developments
 Table 89. Abbott Corporation Information
 Table 90. Abbott Description and Major Businesses
 Table 91. Abbott Product Features and Attributes
 Table 92. Abbott Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Abbott Recent Developments
 Table 94. Eckert & Ziegler Corporation Information
 Table 95. Eckert & Ziegler Description and Major Businesses
 Table 96. Eckert & Ziegler Product Features and Attributes
 Table 97. Eckert & Ziegler Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Eckert & Ziegler Recent Developments
 Table 99. Sonova Holding Corporation Information
 Table 100. Sonova Holding Description and Major Businesses
 Table 101. Sonova Holding Product Features and Attributes
 Table 102. Sonova Holding Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Sonova Holding Recent Developments
 Table 104. Demant Corporation Information
 Table 105. Demant Description and Major Businesses
 Table 106. Demant Product Features and Attributes
 Table 107. Demant Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Demant Recent Developments
 Table 109. Cochlear Corporation Information
 Table 110. Cochlear Description and Major Businesses
 Table 111. Cochlear Product Features and Attributes
 Table 112. Cochlear Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Cochlear Recent Developments
 Table 114. Oticon Medical Corporation Information
 Table 115. Oticon Medical Description and Major Businesses
 Table 116. Oticon Medical Product Features and Attributes
 Table 117. Oticon Medical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Oticon Medical Recent Developments
 Table 119. MED-EL Medical Electronics Corporation Information
 Table 120. MED-EL Medical Electronics Description and Major Businesses
 Table 121. MED-EL Medical Electronics Product Features and Attributes
 Table 122. MED-EL Medical Electronics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. MED-EL Medical Electronics Recent Developments
 Table 124. Masimo Corporation Information
 Table 125. Masimo Description and Major Businesses
 Table 126. Masimo Product Features and Attributes
 Table 127. Masimo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Masimo Recent Developments
 Table 129. Hologic Corporation Information
 Table 130. Hologic Description and Major Businesses
 Table 131. Hologic Product Features and Attributes
 Table 132. Hologic Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Hologic Recent Developments
 Table 134. Varian Medical Systems Corporation Information
 Table 135. Varian Medical Systems Description and Major Businesses
 Table 136. Varian Medical Systems Product Features and Attributes
 Table 137. Varian Medical Systems Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Varian Medical Systems Recent Developments
 Table 139. Raw Materials Key Suppliers
 Table 140. Distributors List
 Table 141. Market Trends and Market Evolution
 Table 142. Market Drivers and Opportunities
 Table 143. Market Challenges, Risks, and Restraints
 Table 144. Research Programs/Design for This Report
 Table 145. Key Data Information from Secondary Sources
 Table 146. Key Data Information from Primary Sources


List of Figures
 Figure 1. Active Medical Implantable Devices Product Picture
 Figure 2. Global Active Medical Implantable Devices Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Implantable Cardiac Pacemaker Product Picture
 Figure 4. Electroencephalographic Stimulator Product Picture
 Figure 5. Cochlear Implant Product Picture
 Figure 6. Gastric Stimulator Product Picture
 Figure 7. Implantable Infusion Pump Product Picture
 Figure 8. Other Product Picture
 Figure 9. Global Active Medical Implantable Devices Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 10. Hospitals
 Figure 11. Specialty Clinic
 Figure 12. Other
 Figure 13. Active Medical Implantable Devices Report Years Considered
 Figure 14. Global Active Medical Implantable Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 16. Global Active Medical Implantable Devices Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 17. Global Active Medical Implantable Devices Revenue Market Share by Region (2020-2031)
 Figure 18. Global Active Medical Implantable Devices Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Implantable Cardiac Pacemaker Revenue Market Share by Player in 2024
 Figure 21. Electroencephalographic Stimulator Revenue Market Share by Player in 2024
 Figure 22. Cochlear Implant Revenue Market Share by Player in 2024
 Figure 23. Gastric Stimulator Revenue Market Share by Player in 2024
 Figure 24. Implantable Infusion Pump Revenue Market Share by Player in 2024
 Figure 25. Other Revenue Market Share by Player in 2024
 Figure 26. Global Active Medical Implantable Devices Revenue Market Share by Type (2020-2031)
 Figure 27. Global Active Medical Implantable Devices Revenue Market Share by Application (2020-2031)
 Figure 28. North America Active Medical Implantable Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Players Active Medical Implantable Devices Revenue (US$ Million) in 2024
 Figure 30. North America Active Medical Implantable Devices Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Active Medical Implantable Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Active Medical Implantable Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Europe Top 5 Players Active Medical Implantable Devices Revenue (US$ Million) in 2024
 Figure 37. Europe Active Medical Implantable Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Europe Active Medical Implantable Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Germany Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 40. France Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 41. U.K. Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 42. Italy Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 43. Russia Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Active Medical Implantable Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 45. Asia-Pacific Top 8 Players Active Medical Implantable Devices Revenue (US$ Million) in 2024
 Figure 46. Asia-Pacific Active Medical Implantable Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 47. Asia-Pacific Active Medical Implantable Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Indonesia Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 49. Japan Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 50. South Korea Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 51. Australia Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 52. India Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 53. Indonesia Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 54. Vietnam Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 55. Malaysia Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 56. Philippines Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 57. Singapore Active Medical Implantable Devices Revenue (2020-2031) & (US$ Million)
 Figure 58. Central and South America Active Medical Implantable Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 59. Central and South America Top 5 Players Active Medical Implantable Devices Revenue (US$ Million) in 2024
 Figure 60. Central and South America Active Medical Implantable Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 61. Central and South America Active Medical Implantable Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 62. Brazil Active Medical Implantable Devices Revenue (2020-2025) & (US$ Million)
 Figure 63. Argentina Active Medical Implantable Devices Revenue (2020-2025) & (US$ Million)
 Figure 64. Middle East and Africa Active Medical Implantable Devices Revenue YoY (2020-2031) & (US$ Million)
 Figure 65. Middle East and Africa Top 5 Players Active Medical Implantable Devices Revenue (US$ Million) in 2024
 Figure 66. South America Active Medical Implantable Devices Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Middle East and Africa Active Medical Implantable Devices Revenue (US$ Million) by Application (2020-2031)
 Figure 68. GCC Countries Active Medical Implantable Devices Revenue (2020-2025) & (US$ Million)
 Figure 69. Israel Active Medical Implantable Devices Revenue (2020-2025) & (US$ Million)
 Figure 70. Egypt Active Medical Implantable Devices Revenue (2020-2025) & (US$ Million)
 Figure 71. South Africa Active Medical Implantable Devices Revenue (2020-2025) & (US$ Million)
 Figure 72. Active Medical Implantable Devices Industry Chain Mapping
 Figure 73. Channels of Distribution (Direct Vs Distribution)
 Figure 74. Bottom-up and Top-down Approaches for This Report
 Figure 75. Data Triangulation
 Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart